Norbert Goebels
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 25, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.
Journal: Science translational medicine
Published: January 21, 2026
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.
Journal: Journal of neuroinflammation
Published: September 15, 2024
Lymphocyte signatures correspond to clinical phenotypes in autoimmune limbic encephalitis.
Journal: Brain communications
Published: July 29, 2024
KSHV infection of B cells primes protective T cell responses in humanized mice.
Journal: Nature communications
Published: July 03, 2023
Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity.
Journal: International journal of molecular sciences
Published: October 14, 2022
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
Journal: Brain : a journal of neurology
Published: October 17, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Journal: Therapeutic advances in neurological disorders
Published: May 27, 2021
Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)
Journal: Der Nervenarzt
Published: May 07, 2021
Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination.
Journal: Immunology
Published: January 22, 2021
Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis.
Journal: Communications biology
Published: January 11, 2021
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
Journal: Brain : a journal of neurology
Published: December 30, 2020
Last Updated: 09/26/2026